Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bujalska M et al. – The results of this study suggest that inhibitors of cyclooxygenases can increase the antihyperalgesic activity of selective antagonists of B2 and B1 receptors in diabetic and toxic neuropathic pain models. These observations may be clinically relevant.


Today in Pain Management...keeping you current

Use of oral ketamine in chronic pain management: A review
European Journal of Pain, 11/02/09

Acute back pain: benefits and risks of current treatments
Current Medical Research and Opinion, 11/19/09

Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial
Diabetic Medicine, 10/01/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address